O
OncoMed Pharmaceuticals
Improving cancer treatment by creating novel medicines
At a glance
- Status
- Listed
- Founded
- 2004
- Headquarters
- Redwood City, United States
- Listing
- IPO 2013
- Sector
- Biotech & Life Sciences
- Outcome tier
- Colt$25–100M revenue
Knowledge graph
News
More headlines
Open roles
OncoMed Pharmaceuticals in the Redwood City ecosystem
The OncoMed Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
- MVMorgenthaler Ventures
U.S. Venture Partners- TGThe Vertical Group
- LPLatterell Venture Partners
Series B and later6 investors entered at this stage
- DVDelphi Ventures
- BPBay Partners
Adams Street Partners- DVDeNovo Ventures
- NVNomura Phase4 Ventures
- PPPhase4 Partners
Source: Dealroom Talent Intelligence.
Alumni founders
Former OncoMed Pharmaceuticals employees who went on to found companies, sorted by Dealroom signal score.
ABAmador BioscienceEst. 2018
STStemcentrxEst. 2008
Scott J. DyllaUnited States
PPPalleon PharmaceuticalsEst. 2016
APAyala PharmaceuticalsEst. 2017
Matti DavisIsraelGlobal footprint
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about OncoMed Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See OncoMed Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.